Celldex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.

About CLDX

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. 

CEO
Anthony S. Marucci
CEOAnthony S. Marucci
Employees
198
Employees198
Headquarters
Hampton, New Jersey
HeadquartersHampton, New Jersey
Founded
1983
Founded1983
Employees
198
Employees198

CLDX Key Statistics

Market cap
2.16B
Market cap2.16B
Price-Earnings ratio
-7.93
Price-Earnings ratio-7.93
Dividend yield
Dividend yield
Average volume
1.10M
Average volume1.10M
High today
$34.51
High today$34.51
Low today
$31.00
Low today$31.00
Open price
$32.48
Open price$32.48
Volume
956.01K
Volume956.01K
52 Week high
$34.51
52 Week high$34.51
52 Week low
$14.40
52 Week low$14.40

Stock Snapshot

As of today, Celldex(CLDX) shares are valued at $32.44. The company's market cap stands at 2.16B, with a P/E ratio of -7.93.

During the trading session on 2026-03-23, Celldex(CLDX) shares reached a daily high of $34.51 and a low of $31.00. At a current price of $32.44, the stock is +4.6% higher than the low and still -6.0% under the high.

Trading activity shows a volume of 956.01K, compared to an average daily volume of 1.1M.

Over the past 52 weeks, Celldex(CLDX) stock has traded between a high of $34.51 and a low of $14.40.

Over the past 52 weeks, Celldex(CLDX) stock has traded between a high of $34.51 and a low of $14.40.

CLDX News

TipRanks 8h
Celldex upgraded to Outperform from Peer Perform at Wolfe Research

Wolfe Research upgraded Celldex (CLDX) to Outperform from Peer Perform with a $44 price target The firm sees a better catalyst setup for the shares in 2026 rela...

Analyst ratings

88%

of 16 ratings
Buy
87.5%
Hold
6.3%
Sell
6.3%

People also own

Based on the portfolios of people who own CLDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.